Larvol Delta - Biomea-Expands-Ongoing-Phase-I-BMF650-Study-to-Optimize-Dose-Selection-for-Phase-II-Development

BMF-650 - Biomea Fusion

https://www.globenewswire.com/news-release/2026/06/05/3307662/0/en/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase.html

Jun 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next